Financials
| Interim Results | Jan. 30, 2025 |
| Results Year Ended 30 April 2024 | Sep. 24, 2024 |
| Interim Results | Jan. 30, 2024 |
| Interim Results | Jan. 25, 2023 |
| Results for the year ended 30 April 2022 | Oct. 28, 2022 |
| Interim Results for the 6 months ended 31 Oct 2021 | Jan. 26, 2022 |
| Results for the year ended 30 April 2021 | Oct. 29, 2021 |
Proxies
| Result of Annual General Meeting | Oct. 25, 2024 |
| Notice of AGM | Oct. 01, 2024 |
| Result of AGM | Nov. 29, 2023 |
| Notice of AGM | Oct. 31, 2023 |
| Result of Annual General Meeting | Nov. 21, 2022 |
| Notice of AGM | Oct. 28, 2022 |
| Result of AGM | Nov. 23, 2021 |
Ownership Update
| Issue of share options | Feb. 20, 2025 |
| Holding(s) in Company | Oct. 24, 2024 |
| Issue of share options | May. 21, 2024 |
| Holding(s) in Company | Dec. 28, 2023 |
| Holding(s) in Company | Dec. 27, 2023 |
| PDMR Notification | Dec. 06, 2023 |
| Issue of share options to Non-Executive Directors | Apr. 21, 2023 |
Announcements
| Scancell presenting at AACR IO conference | Feb. 17, 2025 |
| Notice of Interim Results | Jan. 23, 2025 |
| Modi-1 Vaccine Achieves Early Clinical Validation | Jan. 09, 2025 |
| Result of Retail Offer and Total Voting Rights | Dec. 09, 2024 |
| Result of Placing and Subscription | Dec. 05, 2024 |
| Retail Offer for up to £1 million | Dec. 04, 2024 |
| Proposed fundraise in excess of £8.5 million | Dec. 04, 2024 |